Cohort | Time (Years) | ||||||
---|---|---|---|---|---|---|---|
0.5 | 1 | 2 | 3 | 4 | 5 | ||
A) Elevated-TG analysis | |||||||
Study population with baseline revascularization (1) | Proportion | 0.6620 | 0.5162 | 0.3687 | 0.3120 | 0.2424 | 0.2049 |
At risk | 393 | 257 | 136 | 88 | 40 | 21 | |
Study population with no baseline revascularization (2) | Proportion | 0.6035 | 0.4699 | 0.3380 | 0.2670 | 0.2203 | 0.1876 |
At risk | 13,566 | 9015 | 5127 | 3360 | 1994 | 1350 | |
Comparison group with baseline revascularization (3) | Proportion | 0.6697 | 0.5362 | 0.3777 | 0.3076 | 0.2570 | 0.2124 |
At risk | 336 | 229 | 122 | 85 | 52 | 35 | |
Comparison group with no baseline revascularization (4) | Proportion | 0.5965 | 0.4708 | 0.3434 | 0.2743 | 0.2260 | 0.1931 |
At risk | 13,460 | 9167 | 5292 | 3552 | 2066 | 1400 | |
Clustered P values for between-group comparisons in the elevated-TG analysis | |||||||
1 vs 2 | 1 vs 3 | 1 vs 4 | 2 vs 3 | 2 vs 4 | 3 vs 4 | ||
0.051 | 0.336 | 0.062 | 0.002 | 0.580 | 0.003 | ||
B) High-TG analysis | |||||||
Study population with baseline revascularization (1) | Proportion | 0.6526 | 0.5026 | 0.3474 | 0.2920 | 0.2177 | 0.1910 |
At risk | 191 | 120 | 61 | 42 | 19 | 9 | |
Study population with no baseline revascularization (2) | Proportion | 0.5893 | 0.4552 | 0.3230 | 0.2534 | 0.2040 | 0.1734 |
At risk | 6274 | 4121 | 2310 | 1503 | 880 | 596 | |
Comparison group with baseline revascularization (3) | Proportion | 0.6620 | 0.5094 | 0.3659 | 0.2928 | 0.2560 | 0.2058 |
At risk | 141 | 93 | 53 | 36 | 24 | 16 | |
Comparison group with no baseline revascularization (4) | Proportion | 0.5858 | 0.4587 | 0.3324 | 0.2668 | 0.2226 | 0.1923 |
At risk | 6287 | 4235 | 2421 | 1621 | 949 | 634 | |
Clustered P values for between-group comparisons in the high-TG analysis | |||||||
1 vs 2 | 1 vs 3 | 1 vs 4 | 2 vs 3 | 2 vs 4 | 3 vs 4 | ||
0.153 | 0.483 | 0.263 | 0.039 | 0.124 | 0.075 |